Skip to content
Products
Solutions
Pricing
Resources
Company
Sign in
Request a demo
Search results
511 entries found
Venture Capital
Private Equity
Filters
Data & Research
May 2023
Mapping VC activity: Texas gains ground in Q1, but California still reigns
In Q1, the Lone Star State made big gains in the share of venture capital dollars it brings home.
View
Data & Research
May 2023
Valuations, step-up multiples trended up in Q1
Startup valuations remain well below the lofty heights they reached at the peak of 2021’s bull market. But in the first quarter of 2023, there were signs that the VC valuation environment is growing friendlier.
View
Data & Research
May 2023
As VC deals shrink, convertible fundraisings are on the rise
To lengthen runway and avoid a down round, startups are increasingly embracing SAFEs and convertible notes.
View
Data & Research
May 2023
The 2023 Enterprise Tech 30 list: How does the ET30 universe compare?
Each year, ET30 identifies the most promising startups in enterprise tech. This year, Carta is offering data to contextualize the fundraising metrics for companies in the ET30 universe.
View
Data & Research
May 2023
State of Private Markets: Q1 2023
Q1 2023 was the slowest quarter for both capital raised and deal count since 2017.
View
Data & Research
April 2023
In late-stage VC valuations, what went up has come down—and then some
At Series D and beyond, median round sizes continued to decline for venture-backed startups in Q1 2023.
View
Data & Research
April 2023
Series B valuations ticked up 10% in Q1, the largest leap since 2021
For the first time in a year, Series B valuations are trending up.
View
Investors
April 2023
Qualifying venture capital fund
A qualifying venture capital fund is private fund with no more than 250 beneficial owners and $12 million in assets. It also must meet the statutory definition of a venture capital fund.
View
Data & Research
April 2023
As funding for renewable energy slides, VCs think long-term
Renewable energy companies on Carta raised just $226 million across 16 investments during Q4. Here's how that looks in context.
View
Data & Research
April 2023
Healthtech shows signs of resilience amid venture downturn
Healthtech deal count declined in Q4, but deal value showed a slight uptick.
View
Data & Research
April 2023
First Cut – State of Private Markets: Q1 2023
In Q1 2023, fundraising continued to decline at most stages while valuations rebounded at Series A and B. Learn more in our preview report.
View
Data & Research
March 2023
How VCs are navigating the SaaS slump
SaaS deal counts and dollars raised are down. Here's how SaaS investors see the landscape.
View
Previous
36
37
38
39
40
Next